• SENSEX 82,279.64
    -251.10 (--0.30%)
  • BANKNIFTY 55,355.60
    554.30 (+1.01%)
  • Bharti Airtel
    1,810.10 1,224.50(%)
  • Cochin Shipyard
    2,044.25 2,977.10(%)
  • Garden Reach Sh.
    2,507.00 2,834.60(%)
  • Mazagon Dock
    3,394.80 3,229.00(%)
  • Larsen & Toubro
    3,636.55 3,963.00(%)
  • Bharat Dynamics
    1,940.00 1,821.95(%)
  • Hind.Aeronautics
    5,090.15 5,675.00(%)
  • Kaynes Tech
    6,836.10 7,824.95(%)
  • Rajesh Power
    1,448.00 1,355.00(%)
  • Rail Vikas
    415.00 647.00(%)
  • JSW Infrast
    288.55 218.10(%)
  • Tata Motors
    742.00 1,179.05(%)
  • Waaree Energies
    2,994.85 3,740.75(%)
  • IndusInd Bank
    735.95 605.40(%)
  • Titagarh Rail
    877.20 1,896.50(%)
  • Bharat Electron
    363.80 351.00(%)
  • Tata Power Co.
    409.45 494.85(%)
  • Suzlon Energy
    60.76 40.05(%)
  • Yes Bank
    21.94 27.41(%)
  • Data Pattern
    2,831.10 3,654.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Amrutanjan Health Care Ltd Pharmaceuticals - Indian - Formulations

  • Amrutanjan
  • BSE Code : 17.0
  • ISIN : INE098F01031
717.10 2 (0.24%)
  • As on 16 May 2025 (EOD)
  • Today’s Low

    712.25
  • Today’s High

    724.80
  • Open

    717.95
  • Perv Close

    715.40
  • 52W Low

    544.10
  • 52W High

    862.60

Key Indicators

  • P/E(TTM)

    42.05

  • Mar.Cap (₹Cr.)

    2,073.18

  • Div & Yield %

    0.64

  • Book Value(₹)

    103.00

  • Debt-Equity Ratio

    0.24

  • AGM Date

    15-May-2025

  • EPS

    17.06

  • P/E Ratio

    42.05

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    2,073.18

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    2.89

  • BV (₹)

    103.00

  • Sales( ₹ in Cr.)

    421.23

  • NP (in Cr.)

    44.86

  • NP Var(%)

    13.0

  • Div%

    460.0

  • CPS (₹)

    17.60

  • EPS (₹)

    15.50

  • Traded Value (₹ in Lakhs)

    2,073.90

  • 52 Week High

    862.60

  • 52 Week Low

    544.10

  • Price BSE

    717.0

  • Price NSE

    717.00

  • Market Capital( in Cr.)

    2,073.90

  • P/C Ratio

    40.70

  • P/E Ratio

    46.20

  • Price Vs.BV

    15.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 421.23 379.64 405.84 332.84 261.48 253.23
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 421.23 379.64 405.84 332.84 261.48 253.23
Other Income 16.35 14.54 15.38 11.32 8.32 7.13
Stock Adjustments -2.15 1.73 5.50 -5.01 6.97 3.30
Total Income 435.43 395.91 426.72 339.15 276.77 263.66
EXPENDITURE :            
Raw Materials 209.67 183.71 185.96 135.18 124.05 122.16
Power and Fuel Cost 3.84 3.06 2.66 1.76 2.02 1.87
Employee Cost 47.69 48.81 48.23 41.70 39.36 33.36
Other Manufacturing Expenses 9.86 10.38 8.37 6.66 6.78 5.72
Selling and Administration Expenses 89.23 86.95 84.68 64.72 61.45 59.96
Miscellaneous Expenses 6.87 3.92 1.87 2.97 3.96 2.53
Employee Benefit Expenses 47.69 48.81 48.23 41.70 39.36 33.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 367.17 336.83 331.77 252.99 237.62 225.60
Operating Profit 68.25 59.08 94.95 86.16 39.15 38.04
Interest 0.25 0.22 0.58 0.59 0.34 0.20
Gross Profit 68.00 58.86 94.37 85.57 38.81 37.84
Depreciation 6.06 5.21 3.80 3.67 4.36 3.16
Profit Before Tax 61.94 53.65 90.57 81.90 34.45 34.68
Current Tax 15.94 14.01 23.39 19.73 9.43 10.23
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.03 -0.20 0.00 0.98 -0.06 -0.06
Reported Net Profit 44.97 39.83 67.19 61.19 25.08 24.51
Extraordinary Items 0.11 0.02 0.01 0.07 0.00 0.00
Adjusted Net Profit 44.86 39.81 67.18 61.12 25.08 24.51
Adjustment below Net Profit -35.47 0.00 0.00 0.00 -0.63 -0.51
P & L Balance brought forward 239.89 214.72 161.62 105.13 91.44 74.36
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.18 14.67 14.08 4.71 10.76 6.93
P & L Balance carried down 236.21 239.89 214.72 161.62 105.13 91.44
Dividend 0.00 0.00 5.85 4.68 6.14 3.22
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 460.00 460.00 460.00 420.00 210.00 215.00
Dividend Per Share(Rs) 4.60 4.60 4.60 4.20 2.10 2.15
Earnings Per Share-Unit Curr 15.56 13.63 22.99 20.93 8.58 8.39
Earnings Per Share(Adj)-Unit Curr 15.56 13.63 22.99 20.93 8.58 8.39
Book Value 99.78 99.47 90.70 73.75 54.54 49.86
Book Value(Adj)-Unit Curr 99.78 99.47 90.70 73.75 54.54 49.86

Shareholding Pattern

  • Promoter Group

    46.52%

  • Public Share Holding

    53.44%

  • Custodian

    0.04%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,918,703 37.77 10,918,703 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,529,487 8.75 2,529,487 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,448,190 46.52 13,448,190 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25,460 0.09 24,960 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 664,195 2.30 664,195 28
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,183,984 7.55 2,183,984 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,088,570 3.77 1,088,570 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,962,209 13.71 3,961,709 40
2] Non Institution
Bodies Corporate 449,759 1.56 448,239 238
Clearing Members 128 0.00 128 2
Directors of their Relatives 36,552 0.13 36,552 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 522,415 1.81 522,415 1,128
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 267,900 0.93 267,896 757
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 877,805 3.04 877,805 3
Individuals holding nominal share capital up to Rs. 1 lakh 8,825,001 30.53 8,357,771 49,466
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,330 0.02 4,330 1
Others 390,734 1.35 390,734 3
Sub Total 11,487,704 39.74 11,018,950 51,626
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 12,527 0.04 12,527 1
Total Shares held by Custodians and against which Depository Receipts have been issued 12,527 0.04 12,527 1
Grand Total ( A + B + C ) 28,910,630 100.00 28,441,376 51,674

Company Background

Amrutanjan Health Care LtdPharmaceuticals - Indian - Formulations

  • Amrutanjan Health Care Ltd
  • BSE Code : 17.0
  • ISIN : INE098F01031
  • Incorporation Year

    1936

  • Registered Office

    New 103 Old 42-45 LuzChurch Rd
    Mylapore, Chennai,
    Tamil Nadu-600004

  • Telephone

    91-44-24994164/24994465/24994366

  • FAX

    91-44-24994585

  • Chairman

    S Sambhuprasad

  • Managing Director

    S Sambhuprasad

  • Company Secretary

    M Srinivasan.

  • Auditor

    B S R & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Amrutanjan Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Amrutanjan Healt 717.35 437.58 421.23 42.05 20.84
Abbott India 30,371.20 6,097.18 5,848.91 48.36 44.71
Astrazeneca Phar 7,947.60 1,330.33 1,295.53 204.89 33.26
P & G Health Ltd 5,247.85 1,166.89 1,151.26 36.82 39.76
Glaxosmi. Pharma 2,878.70 3,530.73 3,407.25 53.06 44.44
Cipla 1,502.25 17,645.00 16,574.34 23.52 20.10
Novartis India 855.45 396.75 335.07 20.93 15.57
Guj. Themis Bio. 325.45 174.19 169.82 67.38 44.82
Fermenta Biotec. 288.75 315.24 307.09 27.37 4.10
Bliss GVS Pharma 120.45 638.96 605.46 18.39 11.19
Ambalal Sarabhai 38.18 11.70 3.81 16.32 1.92